Category
Deflation is a different problem from descent. This is the volume half.
The medication is not damaging your face. Fast weight loss is, and it does it through discrete fat compartments that empty at different rates. That mechanism decides which treatments can realistically restore it.
Last reviewed 15 September 2026
Elle reports on Re2O, an injectable derived from human cadaver tissue that has spread through Seoul's clinics on the back of the polynucleotide trend, and links its rise to GLP-1 weight loss. The connection is real: rapid weight loss empties facial fat compartments, and a large market has appeared for anything promising to put volume back without surgery. What these products do not have is the volume. They are skin-quality treatments being pulled toward a structural problem, and the regulatory position on tissue-derived injectables is not what most people assume.
Elle — Beauty, “How Ozempic Is Fueling the Rise of Cadaver-Derived Injectables” — read the original
Read the full guide: GLP-1 Weight Loss and the Face: What Empties, and What Puts It Back →